Aclaris Therapeutics, Inc.
SUBSTITUTED PYRROLOPYRIDINES AS JAK INHIBITORS
Last updated:
Abstract:
The present invention relates to new pyrrolopyridine compounds having the structures of Formula (I)-(IV), wherein the R groups, A, B, C, D and n are as defined in the detailed description, and compositions and their application as pharmaceuticals for the treatment of disease. ##STR00001## Methods of inhibition of JAK kinase activity in a human or animal subject are also provided for the treatment diseases such as pruritus, alopecia, androgenetic alopecia, alopecia areata, vitiligo and psoriasis.
Status:
Application
Type:
Utility
Filling date:
4 May 2020
Issue date:
5 Nov 2020